The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

26 Oct 2020 10:50

RNS Number : 1940D
Ted Baker PLC
26 October 2020
 

 

 

 

26 October 2020

Ted Baker Plc

(the "Company")

 

Notification of Transactions of Persons Discharging Managerial Responsibilities

 

The Company has been notified of the following transaction by the following Person Discharging Managerial Responsibilities ("PDMR").

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

 

Enquiries:

Ted Baker Plc

Peter Hearsey-Zoubie, Company Secretary

Tulchan Communications

Tel: +44 (0) 20 7353 4200

Jonathan Sibun/Jessica Reid/Will Palfreyman

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMRS AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Helen Costello

2

Reason for the notification

a)

Position/status

 

Group Commercial and Business Development Director

b)

Initial notification/Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ted Baker PLC

 

b)

LEI

549300HN14450OU4IL77

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares

 

 

GB0001048619

b)

Nature of the transaction

 

 

Award of nil-cost options pursuant to the Ted Baker Incentive Plan 2020.

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

1

NIL

193,808

d)

Aggregated information

- Aggregated volume

- Price

 

NA

e)

Date of the transaction

 

2020-26-10

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEEKALXEFFA
Date   Source Headline
2nd Feb 20093:10 pmBUSRule 8.3 - TEPNEL LIFE SCIENCES PLC
2nd Feb 20092:55 pmRNSTotal Voting Rights
2nd Feb 20091:55 pmRNSEPT Disclosure
2nd Feb 20091:53 pmRNSEPT Disclosure
2nd Feb 20091:33 pmRNSRule 8.3- Tepnel Life Sciences
2nd Feb 200912:58 pmRNSRule 8.3- (Tepnel Life Sciences Plc)
2nd Feb 200912:21 pmRNSEPT Disclosure
30th Jan 200911:48 amRNSEPT Disclosure
30th Jan 20097:00 amRNSRecommended Cash Offer for Tepnel Life Sciences
29th Jan 20095:10 pmRNSRule 2.10 Announcement
29th Jan 20095:06 pmRNSExercise of Warrants
29th Jan 200912:00 pmRNSEPT Disclosure
28th Jan 20092:45 pmPRNRule 8.3 - Tepnel Life Sciences plc
28th Jan 20099:42 amRNSEPT Disclosure
27th Jan 20099:24 amRNSEPT Disclosure
27th Jan 20098:57 amPRNRule 8.3 - Tepnel Life Sciences
26th Jan 20094:14 pmRNSHolding(s) in Company
26th Jan 20098:22 amRNSEPT Disclosure
23rd Jan 20092:01 pmPRNRule 8.3 - Tepnel Life Sciences plc
23rd Jan 200912:57 pmPRNRule 8.3 - Tepnel Life Sciences
23rd Jan 200912:20 pmRNSEPT Disclosure
23rd Jan 20097:00 amRNSHolding(s) in Company
23rd Jan 20097:00 amRNSRule 2.10 Announcement
22nd Jan 200910:33 amRNSStmnt re Share Price Movement
19th Jan 20094:52 pmRNSHolding(s) in Company
19th Jan 200912:39 pmRNSHolding(s) in Company
8th Jan 20097:00 amRNSTrading Statement
22nd Dec 20084:03 pmRNSNotice of Trading Update
22nd Dec 200811:35 amRNSHolding(s) in Company
17th Dec 20087:05 amRNSHolding(s) in Company
17th Dec 20087:00 amRNSIssue of Equity
26th Nov 20083:13 pmRNSIllinois Selects Tepnel's Cystic Fibrosis Test
21st Nov 20087:00 amRNSHolding(s) in Company
13th Nov 20087:00 amRNSInterim Management Statement
10th Nov 20082:57 pmRNSNotice of Interim Management Statement
28th Oct 20083:20 pmRNSPersons Discharging Managerial Responsibility
24th Oct 20082:35 pmRNSDirector/PDMR Shareholding
20th Oct 200811:32 amRNSHolding(s) in Company
14th Oct 20089:52 amRNSTEPNEL EXPANDS GENETIC SERVICES PORTFOLIO
10th Oct 20089:01 amRNSHolding(s) in Company
2nd Oct 20087:00 amRNSInterim Results
30th Sep 20087:00 amRNSHolding(s) in Company
10th Sep 200812:10 pmRNSGrant of options
4th Sep 20087:00 amRNSAdditional Listing & TVR
2nd Sep 200811:04 amRNSAdditional Listing & TVR
27th Aug 20087:00 amRNSNew DNA Test for Early Detect
14th Aug 20087:00 amRNSNotice of Results
7th Aug 20084:14 pmRNSDirector/PDMR Shareholding
4th Aug 20089:01 amRNSDirector/PDMR Shareholding
31st Jul 20087:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.